These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19104744)

  • 1. Subcutaneous nodule after vaccination with an aluminum-containing vaccine.
    Avcin S; Jazbec J; Jancar J
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Dec; 17(4):182-4. PubMed ID: 19104744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent subcutaneous nodules after immunotherapy injections for allergic asthma.
    Ozden MG; Kefeli M; Aydin F; Senturk N; Canturk T; Turanli AY
    J Cutan Pathol; 2009 Jul; 36(7):812-4. PubMed ID: 19519616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent subcutaneous nodules in patients hyposensitized with aluminum-containing allergen extracts.
    García-Patos V; Pujol RM; Alomar A; Cisteró A; Curell R; Fernández-Figueras MT; de Moragas JM
    Arch Dermatol; 1995 Dec; 131(12):1421-4. PubMed ID: 7492132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum granuloma in a child secondary to DTaP-IPV vaccination: A case report.
    Haag CK; Dacey E; Hamilton N; White KP
    Pediatr Dermatol; 2019 Jan; 36(1):e17-e19. PubMed ID: 30488642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy].
    Hernández I; Sanmartín O; Cardá C; Góme S; Alfaro A
    Actas Dermosifiliogr; 2008 Apr; 99(3):213-6. PubMed ID: 18358197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-vaccination granuloma due to aluminium hydroxide].
    Bordet AL; Michenet P; Cohen C; Arbion F; Ekindi N; Bonneau C; Kerdraon R; Coville M
    Ann Pathol; 2001 Apr; 21(2):149-52. PubMed ID: 11373585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium.
    Netterlid E; Bruze M; Hindsén M; Isaksson M; Olin P
    Vaccine; 2004 Sep; 22(27-28):3698-706. PubMed ID: 15315849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey.
    Verdier F; Burnett R; Michelet-Habchi C; Moretto P; Fievet-Groyne F; Sauzeat E
    Vaccine; 2005 Feb; 23(11):1359-67. PubMed ID: 15661384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subcutaneous nodules and sensitivity to aluminum in patients undergoing hyposensitivity immunotherapy].
    García-Patos V; Alomar A; Lleonart R; Cistero A; Matias-Guiu X
    Med Cutan Ibero Lat Am; 1990; 18(2):83-8. PubMed ID: 2145483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous sarcoidosis localised to sites of previous desensitizing injections.
    Marcoval J; Moreno A; Mañá J
    Clin Exp Dermatol; 2008 Mar; 33(2):132-4. PubMed ID: 18076694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneously reported adverse reactions after diphtheria-tetanus revaccination at 4-6 years of age--a comparison of two vaccines with different amounts of diphtheria toxoid.
    Thierry-Carstensen B; Sjølin Frederiksen M; Andersen PH; Stellfeld M
    Vaccine; 2004 Dec; 23(5):668-71. PubMed ID: 15542188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Wells syndrome (eosinophilic cellulitis) after vaccination: A case report and review of the literature.
    Yu AM; Ito S; Leibson T; Lavi S; Fu LW; Weinstein M; Skotnicki SM
    Pediatr Dermatol; 2018 Sep; 35(5):e262-e264. PubMed ID: 29998475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
    Kim H; Lim KY; Kang J; Park JW; Park SH
    Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
    Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
    Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
    Brenner A
    Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent nodules at injection sites (aluminium granuloma) -- clinicopathological study of 14 cases with a diverse range of histological reaction patterns.
    Chong H; Brady K; Metze D; Calonje E
    Histopathology; 2006 Jan; 48(2):182-8. PubMed ID: 16405667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations.
    Vogelbruch M; Nuss B; Körner M; Kapp A; Kiehl P; Bohm W
    Allergy; 2000 Sep; 55(9):883-7. PubMed ID: 11003454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminium hydroxide granuloma.
    Erdohazi M; Newman RL
    Br Med J; 1971 Sep; 3(5775):621-3. PubMed ID: 5569985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous ulcerating nodules after many years of immunotherapy].
    Bouten H; Nijsten TE; Noordhoek Hegt V
    Ned Tijdschr Geneeskd; 2016; 160():A9554. PubMed ID: 26860748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.